Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer
5 other identifiers
interventional
35
1 country
1
Brief Summary
This pilot clinical trial studies how well Prepare to Care kit works in improving caregiver support in patients with stage I-IV head and neck cancer that is new or has come back. Prepare to Care kit may increase knowledge about head and neck cancer and enhance stress-management skills.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2017
CompletedFirst Posted
Study publicly available on registry
January 26, 2017
CompletedStudy Start
First participant enrolled
May 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2020
CompletedResults Posted
Study results publicly available
July 1, 2021
CompletedJanuary 9, 2023
December 1, 2022
2.9 years
January 17, 2017
April 23, 2021
December 14, 2022
Conditions
Outcome Measures
Primary Outcomes (10)
Number of Participants Noting Quite a Bit/Very Much Helpful to Survey Questions
10-item quantitative survey will be developed for study to assess how much caregivers liked different aspects of the intervention. Acceptability will be summarized quantitatively and qualitatively. These acceptability questions were asked only of caregivers in the intervention group - Group 1 Supportive Care (Prepare to Care Kit). All data is based on participants answering the acceptability questions as "Quite a Bit/Very Much Helpful" for the intervention materials. Not all participants answered this part of the outcome measure.
Six weeks post radiation therapy
Accrual Assessed by Number of Caregivers Who Agreed to Participate Divided by the Number of Months of Recruitment
38 patient/caregiver dyads agreed to participate, 22 months of recruitment, for accrual rate of 1.7 (caregiver) participants per month
Up to 1 year
Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)
21-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health). The CRA has been tested in cancer caregivers; demonstrated validity and reliability. Minimum and maximum scoring scale: BASELINE: Scores for esteem 15-31; lack of family support 5-15, impact of finances 3-12, impact of schedule 12-23, impact of health 11-16). AFTER RADIOTHERAPY: Scores for esteem 20-31; lack of family support 9-17, impact of finances 7-11, impact of schedule 14-22, impact of health 12-17). The higher the score the more the item being assessed impacted the participant.
Baseline and following radiotherapy, assessed up to 1 year
Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD)
The score is the sum of the 20 questions. Possible scoring range is 0-60. A score of 16 points or more is considered depressed.
Before and after radiotherapy, assessed up to 1 year
Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)
35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns). The Cqol-Canc has demonstrated validity and reliability. Minimum and maximum score at baseline is a range of 9-78 and after radiotherapy a range of 2-73. The higher the score the greater the level of change in the quality of life for participants.
Before and after radiotherapy, assessed up to 1 year
Frequency of Intervention Modules Utilized Assessed by Caregiver Logs
Data on intervention resources used and time spent using them based on caregivers in intervention group
Up to 1 year
Number of Participants in Agreement to Perform Interventions
Participation assessed by number of eligible participants who agreed to participate and complete study interventions.
Up to 1 year
Retention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to Participate
Up to 1 year
Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)
A 3-item instrument developed for study to evaluate self-efficacy in APMR. Minimum to maximum scores range from 3-27. Higher scores demonstrate higher self efficacy in participants.
At baseline and up to the end of radiotherapy, assessed up to 1 year
Self-efficacy in Coping With Cancer Caregiver Inventory
21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions); demonstrated validity and reliability. Minimum and maximum scores range from 10-63. Higher scores indicate higher self-efficacy in coping with cancer from the participants.
At baseline and up to the end of radiotherapy, assessed up to 1 year
Other Outcomes (1)
Salivary Cortisol Collection
Up to 1 year
Study Arms (2)
Group I Supportive Care (Prepare to Care kit)
EXPERIMENTALCaregivers watch introduction video on a DVD over 10 minutes at baseline. Caregivers receive Prepare to Care kit including 8 workbook modules and complete at least 1 module over 30-45 minutes each week. Caregivers also attend interventionist session over 10-30 minutes weekly.
Group II Control Group
EXPERIMENTALCaregivers received standard of care throughout course of intervention, with option to receive study intervention at end of study
Interventions
Attend interventionist sessions
Watch video on a DVD
Complete modules of the Prepare to Care kit
Ancillary studies
Ancillary studies
Obtained at three times a day (at awakening, 30 minutes post awakening and bedtime) for two consecutive days for eligible caregivers in both groups. Samples collected by placing a cotton ball under the tongue for approximately 1-2 minutes which is subsequently stored in a plastic tube and refrigerated.
Eligibility Criteria
You may qualify if:
- CAREGIVERS:
- CARE-RECIPIENTS:
- Has a new or recurrent American Joint Committee on Cancer (AJCC) stage I-IV squamous cell carcinoma of the upper aerodigestive tract (including lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, and larynx cancers)
- Has planned external beam radiotherapy (+/- chemotherapy) for 6-7 weeks
- Has an informal (unpaid) caregiver during radiation therapy who is participating in study
You may not qualify if:
- CAREGIVERS: Has a current cancer diagnosis
- CAREGIVERS: Cannot read/communicate in English
- CAREGIVERS: Have an endocrine disorder (e.g., diabetes and thyroid disorders), or is currently taking a steroid based medication will not be eligible to participate in the saliva portion of the study
- CARE-RECIPIENTS: Cannot read/communicate in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, 27157, United States
Related Publications (1)
Nightingale C, Sterba KR, Levine B, Tooze JA, Greven K, Frizzell B, Hughes RT, Snavely A, Lesser GJ, Norona S, Pleasant K, Weaver KE. Feasibility and Acceptability of a Multi-Modality Self-Management Intervention for Head and Neck Cancer Caregivers: A Pilot Randomized Trial. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221098984. doi: 10.1177/15347354221098984.
PMID: 35575280DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Principal Investigator
- Organization
- Wake Forest Baptist Comprehensive Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Chandylen Nightingale
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2017
First Posted
January 26, 2017
Study Start
May 15, 2017
Primary Completion
April 10, 2020
Study Completion
April 10, 2020
Last Updated
January 9, 2023
Results First Posted
July 1, 2021
Record last verified: 2022-12